Chronic obstructive pulmonary disease and cardiovascular disease (Q38111151)

29 August 2017

title

Chronic obstructive pulmonary disease and cardiovascular disease. (English)

1 reference

chronic obstructive pulmonary disease

29 August 2017

main subject

1 reference

based on heuristic

inferred from title

cardiovascular disease

1 reference

Surya P Bhatt

1

1 reference

29 August 2017

Mark T Dransfield

series ordinal

2

1 reference

29 August 2017

publication date

31 May 2013

1 reference

29 August 2017

published in

Translational Research

1 reference

29 August 2017

volume

162

1 reference

29 August 2017

issue

4

1 reference

29 August 2017

page(s)

237-251

1 reference

Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Systemic inflammation and comorbidities in chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Hospitalizations and mortality in the Lung Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

High prevalence of undiagnosed airflow limitation in patients with cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. SPRINT Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Lung function and risk for heart failure among older adults: the Health ABC Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Population-based study of lung function and incidence of heart failure hospitalisations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Epidemiology of diastolic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Sub-clinical left and right ventricular dysfunction in patients with COPD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Left ventricular diastolic dysfunction in patients with COPD in the presence and absence of elevated pulmonary arterial pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Echo-Doppler evaluation of left ventricular impairment in chronic cor pulmonale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Percent emphysema, airflow obstruction, and impaired left ventricular filling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Comparison of risk factors for stroke incidence and stroke mortality in 20 years of follow-up in men and women in the Renfrew/Paisley Study in Scotland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Lower pulmonary function and cerebral subclinical abnormalities detected by MRI: the Atherosclerosis Risk in Communities study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Lung function as a risk factor for subarachnoid hemorrhage: a prospective cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

An association between chronic obstructive pulmonary disease and abdominal aortic aneurysm beyond smoking: results from a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Multifocal Atrial Tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Factors associated with the development of atrial fibrillation in COPD patients: the role of P-wave dispersion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Arrhythmias as trigger for acute exacerbations of chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Effect of blood gas derangement on QTc dispersion in severe chronic obstructive pulmonary disease: evidence of an electropathy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

COPD in Japan: the Nippon COPD Epidemiology study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

The epidemiology of heart failure: the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

COPD as a disease of accelerated lung aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Cigarette smoke induces cellular senescence via Werner's syndrome protein down-regulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Oxidative stress and accelerated vascular aging: implications for cigarette smoking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Estimates of global mortality attributable to smoking in 2000

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Difficulties identifying and targeting COPD and population-attributable risk of smoking for COPD: a population study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Risk of COPD from exposure to biomass smoke: a metaanalysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Smoking and risk of myocardial infarction in women and men: longitudinal population study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Household air pollution is a major avoidable risk factor for cardiorespiratory disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Obstructive airway diseases in women exposed to biomass smoke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Particulate air pollution and survival in a COPD cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Health effects of fine particulate air pollution: lines that connect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Gender and chronic obstructive pulmonary disease: why it matters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

The growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

The antiestrogenic effect of cigarette smoking in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Dietary determinants of long-term incidence of chronic nonspecific lung diseases. The Zutphen Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Cured meat consumption, lung function, and chronic obstructive pulmonary disease among United States adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Inflammation, atherosclerosis, and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Particulate air pollution induces progression of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Local and Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Future treatments for chronic obstructive pulmonary disease and its comorbidities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

The cytokine network in asthma and chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Endothelial function and chronic exposure to air pollution in normal male subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Long-term Exposure to Ambient Particulate Matter and Prevalence of Subclinical Atherosclerosis in the Multi-Ethnic Study of Atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Ischemic Heart Disease Events Triggered by Short-Term Exposure to Fine Particulate Air Pollution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Cigarette Smoking Acutely Increases Platelet Thrombus Formation in Patients With Coronary Artery Disease Taking Aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Role of cigarette smoking and gender in acute coronary syndrome events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Risk of myocardial infarction and stroke after acute infection or vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Impaired lung function and subclinical atherosclerosis. The ARIC Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Association between peak expiratory flow and the development of carotid atherosclerotic plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Airflow limitation in smokers is associated with subclinical atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Atherosclerotic plaques in the internal carotid artery and associations with lung function assessed by different methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Association of COPD with carotid wall intima-media thickness in vascular surgery patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Chronic obstructive pulmonary disease and lipid core carotid artery plaques in the elderly: the Rotterdam Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Coronary Artery Calcium Score Combined With Framingham Score for Risk Prediction in Asymptomatic Individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

CT emphysema predicts thoracic aortic calcification in smokers with and without COPD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Pulmonary function is associated with distal aortic calcium, not proximal aortic distensibility. MESA lung study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Systemic inflammation in chronic obstructive pulmonary disease: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

C-reactive protein in patients with COPD, control smokers and non-smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Excessive aortic inflammation in chronic obstructive pulmonary disease: an 18F-FDG PET pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Lung function, coronary artery calcification, and metabolic syndrome in 4905 Korean males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Carotid atherosclerosis in patients with untreated chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Is chronic obstructive pulmonary disease associated with increased arterial stiffness?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Systemic elastin degradation in chronic obstructive pulmonary disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Oxidative stress and regulation of glutathione in lung inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Systemic oxidative stress in asthma, COPD, and smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Cardiovascular injury and repair in chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

The state of genome-wide association studies in pulmonary disease: a new perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Series "matrix metalloproteinases in lung health and disease": Matrix metalloproteinases in COPD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Glutathione S-Transferase Gene Polymorphism as a Susceptibility Factor for Acute Myocardial Infarction and Smoking in the North Indian Population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Interaction between smoking and genetic factors in the development of chronic bronchitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Inhibition of tissue angiotensin-converting enzyme with quinapril reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Differential effects of short-term ace- and AT1-receptor inhibition on postischemic injury and leukocyte adherence in vivo and in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Endothelial dysfunction in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Physical activity in COPD patients: patterns and bouts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Peripheral and cerebral atherothrombosis and cardiovascular events in different vascular territories: insights from the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Left ventricular diastolic dysfunction in COPD may manifest myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Dynamic hyperinflation is associated with a poor cardiovascular response to exercise in COPD patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

The heart is not always in good hands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: an MRI study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Ventricular interaction: from bench to bedside.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Left Ventricular Dysfunction Induced by Nonsevere Idiopathic Pulmonary Arterial Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Arrhythmogenesis in patients with stable chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Cardiovascular autonomic neuropathy in chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

The QTc interval, autonomic neuropathy and mortality in hypoxaemic COPD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Relevance of lung ultrasound in the diagnosis of acute respiratory failure: the BLUE protocol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Pulmonary function abnormalities in chronic severe cardiomyopathy preceding cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Serial pulmonary function in patients with acute heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

The impact of heart failure on the classification of COPD severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Death certificate reporting of confirmed airways obstructive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Increased risk of myocardial infarction and stroke following exacerbation of COPD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Unrecognised ventricular dysfunction in COPD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Diastolic dysfunction and COPD exacerbation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Chronic obstructive pulmonary disease after myocardial infarction in the community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Impact of COPD on long-term outcome after ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Impact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Prevalence and prognosis of chronic obstructive pulmonary disease among 8167 Middle Eastern patients with acute coronary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Bronchodilator use and the risk of arrhythmia in COPD: part 1: Saskatchewan cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Bronchodilator use and the risk of arrhythmia in COPD: part 2: reassessment in the larger Quebec cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Respiratory illness, beta-agonists, and risk of idiopathic dilated cardiomyopathy. The Washington, DC, Dilated Cardiomyopathy Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Lack of association between ipratropium bromide and mortality in elderly patients with chronic obstructive airway disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Use of tiotropium Respimat Soft Mist Inhaler versus HandiHaler and mortality in patients with COPD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Respiratory medications and the risk of cardiac arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Cardiovascular safety in patients receiving roflumilast for the treatment of COPD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Azithromycin and the risk of cardiovascular death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Azithromycin for the secondary prevention of coronary events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Impact of statins and ACE inhibitors on mortality after COPD exacerbations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Statin use in COPD patients is associated with a reduction in mortality: a national cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Statin use is associated with reduced mortality in COPD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Beta-blocker use and COPD mortality: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Co-morbidity in COPD: the effects of cardiovascular drug therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Effects of cardiovascular drugs on mortality in severe chronic obstructive pulmonary disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

The clinical importance of dynamic lung hyperinflation in COPD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

Elevated high-sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2013.05.001

10.1016/J.TRSL.2013.05.001

7 January 2021

Identifiers

DOI

1 reference

29 August 2017

1 reference